Advertisement
Screener

MAP PHARMACEUTICALS, INC. Proceeds from Stock Plans

MAP PHARMACEUTICALS, INC. Proceeds from Stock Plans

MAP PHARMACEUTICALS, INC. reported Proceeds from Stock Plans of $7.84 million for the 111-month period ending 2012-09-30, per its 10-Q filed 2012-11-06.

Discontinued › Cash Flow › Financing Activities

us-gaap:ProceedsFromStockPlans · last filed 2012-11-06

  • MAP PHARMACEUTICALS, INC. proceeds from stock plans for the quarter ending 2012-09-30 was $255.00K, a 810.71% increase year-over-year.
  • MAP PHARMACEUTICALS, INC. proceeds from stock plans for the quarter ending 2012-06-30 was $683.00K, a 47.66% decline year-over-year.
  • MAP PHARMACEUTICALS, INC. proceeds from stock plans for the quarter ending 2012-03-31 was $190.00K, a 58.06% decline year-over-year.
  • MAP PHARMACEUTICALS, INC. proceeds from stock plans for the quarter ending 2011-12-31 was $703.00K, a 18.75% increase year-over-year.
  • MAP PHARMACEUTICALS, INC. proceeds from stock plans for fiscal 2011 was $2.49M, a 9.50% increase from fiscal 2010.
  • MAP PHARMACEUTICALS, INC. proceeds from stock plans for fiscal 2010 was $2.27M, a 95.61% increase from fiscal 2009.
  • MAP PHARMACEUTICALS, INC. proceeds from stock plans for fiscal 2009 was $1.16M.
Period endProceeds from Stock Plans 3 monthProceeds from Stock Plans 6 monthProceeds from Stock Plans 9 monthProceeds from Stock Plans 12 monthProceeds from Stock Plans 96 monthProceeds from Stock Plans 99 monthProceeds from Stock Plans 102 monthProceeds from Stock Plans 105 monthProceeds from Stock Plans 108 monthProceeds from Stock Plans 111 month
2012-09-30$255.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-06
$938.00K
derived: sum of 2 quarters · filed 2012-11-06
$1.13M
10-Q · filed 2012-11-06
$1.83M
derived: sum of 4 quarters · filed 2012-11-06
$7.84M
10-Q · filed 2012-11-06
2012-06-30$683.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2012-07-27
$873.00K
10-Q · filed 2012-07-27
$1.58M
derived: sum of 3 quarters · filed 2012-07-27
$1.60M
derived: sum of 4 quarters · filed 2012-11-06
$7.58M
10-Q · filed 2012-07-27
2012-03-31$190.00K
10-Q · filed 2012-05-08
$893.00K
derived: sum of 2 quarters · filed 2012-05-08
$921.00K
derived: sum of 3 quarters · filed 2012-11-06
$2.23M
derived: sum of 4 quarters · filed 2012-11-06
$6.90M
10-Q · filed 2012-05-08
2011-12-31$703.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-30
$731.00K
derived: sum of 2 quarters · filed 2012-11-06
$2.04M
derived: sum of 3 quarters · filed 2012-11-06
$2.49M
10-K · filed 2012-03-30
$6.71M
10-K · filed 2012-03-30
2011-09-30$28.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-06
$1.33M
derived: sum of 2 quarters · filed 2012-11-06
$1.79M
10-Q · filed 2012-11-06
$2.38M
derived: sum of 4 quarters · filed 2012-11-06
$6.01M
10-Q/A · filed 2012-03-30
2011-06-30$1.30M
derived: 10-Q 6 month − 10-Q 3 month · filed 2012-07-27
$1.76M
10-Q · filed 2012-07-27
$2.35M
derived: sum of 3 quarters · filed 2012-07-27
$2.55M
derived: sum of 4 quarters · filed 2012-07-27
$5.98M
10-Q/A · filed 2012-03-30
2011-03-31$453.00K
10-Q · filed 2012-05-08
$1.04M
derived: sum of 2 quarters · filed 2012-05-08
$1.25M
derived: sum of 3 quarters · filed 2012-05-08
2010-12-31$592.00K
derived: 10-K 12 month − 10-Q/A 9 month · filed 2012-03-30
$794.00K
derived: sum of 2 quarters · filed 2012-03-30
$2.27M
10-K · filed 2012-03-30
2010-09-30$202.00K
derived: 10-Q/A 9 month − 10-Q/A 6 month · filed 2012-03-30
$1.68M
10-Q/A · filed 2012-03-30
2010-06-30$1.48M
10-Q/A · filed 2012-03-30
2009-12-31$1.16M
10-K · filed 2012-03-30